EDGAR Filing Documents for 0001096906-15-000373

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001096906-15-000373

Filing Date

2015-04-09

Accepted

2015-04-09 11:44:05

Documents

Period of Report

2014-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	SIGHPATH PHARMA 10K 2014-12-31	signpath.htm	10-K	1338244
2	FORM OF CLASS D COMMON STOCK PURCHASE WARRANT	signpathexh49.htm	EX-4.9	127380
3	FORM OF SERIES D SUBSCRIPTION AGREEMENT	signpathexh410.htm	EX-4.10	466573
4	AMENDMENT DATED APRIL 12, 2012 TO THE LIPSOMAL FOUNDATION MANUFACTURING AGREEMEN	signpathexh106.htm	EX-10.6	24218
5	AMENDMENT, DATED AUGUST 23, 2012, TO THE LIPOSOMAL FORMULATION MANUFACTURING AGR	signpathexh107.htm	EX-10.7	19229
6	EXCLUSIVE LICENSE AGREEMENT, DATED JUNE 5, 2013, WITH JOHNS HOPKINS UNIVERSITY.	signpathexh109.htm	EX-10.9	229771
7	PATENT AND TECHNOLOGY LICENSE AGREEMENT DATED NOVEMBER 25, 2015, BETWEEN THE REG	signpathexh1011.htm	EX-10.11	120330
8	PLACEMENT AGENCY AGREEMENT DATED AS OF SEPTEMBER 17, 2014 BY AND BETWEEN SIGNPAT	signpathexh1012.htm	EX-10.12	170252
9	SPONSORED RESEARCH AGREEMENT BY AND BETWEEN THE REGISTRANT AND UNIVERSITY OF NOR	signpathexh1015.htm	EX-10.15	119702
10	AMENDMENT NO. 1, DATED JULY 18, 2014, TO THE SPONSORED RESEARCH AGREEMENT BY AND	signpathexh1016.htm	EX-10.16	33320
11	AMENDMENT NO. 1, DATED DECEMBER 12, 2014, TO THE EMPLOYMENT AGREEMENT BY AND BET	signpathexh1017.htm	EX-10.17	15734
12	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN	signpathexh311.htm	EX-31.1	17473
13	CERTIFICATE OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT	signpathexh321.htm	EX-32.1	7926
	Complete submission text file	0001096906-15-000373.txt		5522191

Data Files

Seq	Description	Document	Type	Size
14	XBRL INSTANCE	sppxbrl-20141231.xml	EX-101.INS	425772
15	XBRL SCHEMA	sppxbrl-20141231.xsd	EX-101.SCH	44235
16	XBRL CALCULATION	sppxbrl-20141231_cal.xml	EX-101.CAL	11311
17	XBRL DEFINITION	sppxbrl-20141231_def.xml	EX-101.DEF	70879
18	XBRL LABEL	sppxbrl-20141231_lab.xml	EX-101.LAB	144155
19	XBRL PRESENTATION	sppxbrl-20141231_pre.xml	EX-101.PRE	148533

Mailing Address 3477 CORPORATE PARKWAY, SUITE 100 CENTER VALLEY PA 18034

Business Address 3477 CORPORATE PARKWAY, SUITE 100 CENTER VALLEY PA 18034 215-538-9996

SignPath Pharma, Inc. (Filer) CIK: 0001455694 (see all company filings)